UTILITY OF HALP SCORE IN PREDICTING MORTALITY IN ACUTE ISCHEMIC STROKE

J WAZIR; WUH KHAN; . SHUMAILA; M YASEEN; IU HAQ; MM RAZZAQ

doi:10.54112/bcsrj.v2024i1.1069

Authors

J WAZIR Combined Military Hospital (CMH), Peshawar, Pakistan
WUH KHAN Combined Military Hospital (CMH), Peshawar, Pakistan
. SHUMAILA Combined Military Hospital (CMH), Peshawar, Pakistan
M YASEEN Combined Military Hospital (CMH), Peshawar, Pakistan
IU HAQ Combined Military Hospital (CMH), Peshawar, Pakistan
MM RAZZAQ Combined Military Hospital (CMH), Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1069

Keywords:

Acute ischemic stroke, cerebrovascular accidents, HALP score, hypertension, stroke cognitive impairment

Abstract

Acute ischemic stroke (AIS) poses significant mortality and morbidity risks. The HALP score, integrating hemoglobin, albumin, lymphocytes, and platelets, has been proposed as a potential marker for predicting outcomes in AIS patients. This study evaluates the predictive utility of the HALP score for mortality and recurrence in these patients. Objective: To assess the predictive value of the HALP score at admission for mortality and recurrent stroke within one and six months post-admission. Methods: In this prospective hospital-based cohort study, 1206 patients presenting with AIS were included. Patients were stratified into tertiles based on their HALP score at admission. The study accounted for age, gender, medical history, and NIHSS scores at baseline. Results: The cohort's mean age was 60.55 years, with 33.8% female. Patients with lower HALP scores showed worse outcomes, with 1.5% lost to follow-up and 1.3% experiencing poor outcomes at one month. At six months, 9.2% were lost to follow-up, and 8.8% had poor outcomes. Higher HALP scores correlated with reduced risk of adverse outcomes, with adjusted hazard ratios of 0.8 (95% CI: 0.05–0.19) at one month and 0.21 (95% CI: 0.13–0.34) at six months. Sensitivity and specificity were 16.1% and 25.4%, respectively, at one month and 24.6% and 36.4% at six months. Conclusion: The HALP score at admission significantly predicts mortality and recurrent stroke within the first six months post-AIS, supporting its integration into initial assessment protocols.

Downloads

Download data is not yet available.

References

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. circulation. 2016;133(4):e38-e360.

Esenwa CC, Elkind MS. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nature Reviews Neurology. 2016;12(10):594-604.

Lau LMd, Leebeek FW, Maat MPd, Koudstaal PJ, Dippel DW. A review of hereditary and acquired coagulation disorders in the aetiology of ischaemic stroke. International Journal of Stroke. 2010;5(5):385-94.

Akimoto T, Hara M, Morita A, Uehara S, Nakajima H. Relationship between nutritional scales and prognosis in elderly patients after acute ischemic stroke: comparison of controlling nutritional status score and geriatric nutritional risk index. Annals of Nutrition and Metabolism. 2021;77(2):116-23.

Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y. Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study. BMC neurology. 2010;10:1-7.

Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators of inflammation. 2019;2019(1):9213074.

Milionis H, Papavasileiou V, Eskandari A, D'Ambrogio-Remillard S, Ntaios G, Michel P. Anemia on admission predicts short-and long-term outcomes in patients with acute ischemic stroke. International Journal of Stroke. 2015;10(2):224-30.

Xu S-S, Li S, Xu H-X, Li H, Wu C-T, Wang W-Q, et al. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. World journal of gastroenterology. 2020;26(8):828.

Tian M, Li Y, Wang X, Tian X, Pei L-l, Wang X, et al. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is associated with poor outcome of acute ischemic stroke. Frontiers in Neurology. 2021;11:610318.

Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. stroke. 1993;24(1):35-41.

Brouns R, De Deyn P. The complexity of neurobiological processes in acute ischemic stroke. Clinical neurology and neurosurgery. 2009;111(6):483-95.

Kim JY, Park J, Chang JY, Kim S-H, Lee JE. Inflammation after ischemic stroke: the role of leukocytes and glial cells. Experimental neurobiology. 2016;25(5):241.

Yang M, Pan Y, Li Z, Yan H, Zhao X, Liu L, et al. Platelet count predicts adverse clinical outcomes after ischemic stroke or TIA: subgroup analysis of CNSR II. Frontiers in Neurology. 2019;10:370.

Kim J, Song T-J, Park JH, Lee HS, Nam CM, Nam HS, et al. Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. Atherosclerosis. 2012;222(2):464-7.

Organization WH. Task force on stroke and other cerebrovascular disorders: Recommendations on stroke prevention, diagnosis, and therapy. Stroke. 1989;20:1407-31.

Dziedzic T, Slowik A, Szczudlik A. Serum albumin level as a predictor of ischemic stroke outcome. Stroke. 2004;35(6):e156-e8.

Sacco S, Marini C, Olivieri L, Pistoia F, Carolei A. Contribution of hematocrit to early mortality after ischemic stroke. European neurology. 2007;58(4):233-8.

Taverna M, Marie A-L, Mira J-P, Guidet B. Specific antioxidant properties of human serum albumin. Annals of intensive care. 2013;3:1-7.

Lam FW, Cruz MA, Leung H-CE, Parikh KS, Smith CW, Rumbaut RE. Histone induced platelet aggregation is inhibited by normal albumin. Thrombosis research. 2013;132(1):69-76.

Kimberly WT, Lima FO, O’Connor S, Furie KL. Sex differences and hemoglobin levels in relation to stroke outcomes. Neurology. 2013;80(8):719-24.

Barlas RS, Honney K, Loke YK, McCall SJ, Bettencourt‐Silva JH, Clark AB, et al. Impact of hemoglobin levels and anemia on mortality in acute stroke: analysis of UK regional registry data, systematic review, and meta‐analysis. Journal of the American Heart Association. 2016;5(8):e003019.

McDonald RJ, Cloft HJ, Kallmes DF. Intracranial hemorrhage is much more common after carotid stenting than after endarterectomy: evidence from the National Inpatient Sample. Stroke. 2011;42(10):2782-7.

Zhang Q, Lei Y-X, Wang Q, Jin Y-P, Fu R-L, Geng H-H, et al. Serum albumin level is associated with the recurrence of acute ischemic stroke. The American journal of emergency medicine. 2016;34(9):1812-6.